We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$5.78B
AUM Growth
+$633M
Cap. Flow
+$111M
Cap. Flow %
1.93%
Top 10 Hldgs %
34.84%
Holding
515
New
41
Increased
255
Reduced
153
Closed
11

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$13.3M
2
DAL icon
Delta Air Lines
DAL
+$10.1M
3
CRM icon
Salesforce
CRM
+$9.38M
4
SO icon
Southern Company
SO
+$9.08M
5
NOW icon
ServiceNow
NOW
+$8.11M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$13.9M
2
NVDA icon
NVIDIA
NVDA
+$10.2M
3
MCD icon
McDonald's
MCD
+$6.57M
4
DG icon
Dollar General
DG
+$6M
5
SBUX icon
Starbucks
SBUX
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 26.31%
2 Financials 10.95%
3 Healthcare 8.67%
4 Industrials 6.28%
5 Consumer Discretionary 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTVA icon
326
Corteva
CTVA
$59.7B
$697K 0.01%
9,352
+9
+0.1% +$600
OTIS icon
327
Otis Worldwide
OTIS
$27.4B
$696K 0.01%
7,024
-392
-5% -$37.8K
ED icon
328
Consolidated Edison
ED
$41.6B
$694K 0.01%
+6,916
New +$732K
IJK icon
329
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$686K 0.01%
7,537
+557
+8% +$47.7K
WMB icon
330
Williams Companies
WMB
$90.5B
$683K 0.01%
10,882
-202
-2% -$11.9K
FE icon
331
FirstEnergy
FE
$28.9B
$676K 0.01%
16,801
+1,813
+12% +$74.8K
CVS icon
332
CVS Health
CVS
$137B
$673K 0.01%
9,757
-10,028
-51% -$658K
CLX icon
333
Clorox
CLX
$11.6B
$668K 0.01%
5,563
-31
-0.6% -$4.14K
UL icon
334
Unilever
UL
$131B
$667K 0.01%
9,692
+657
+7% +$46.1K
ARES icon
335
Ares Management
ARES
$28.5B
$664K 0.01%
3,836
+2,087
+119% +$330K
IYJ icon
336
iShares US Industrials ETF
IYJ
$1.98B
$663K 0.01%
4,656
BNKK
337
Bonk Inc
BNKK
$8.96M
$657K 0.01%
56,857
IHF icon
338
iShares US Healthcare Providers ETF
IHF
$1.18B
$656K 0.01%
13,475
-200
-1% -$9.85K
PLTR icon
339
Palantir
PLTR
$295B
$651K 0.01%
+4,775
New +$560K
IYF icon
340
iShares US Financials ETF
IYF
$4.39B
$644K 0.01%
5,323
-149
-3% -$16.8K
VBR icon
341
Vanguard Small-Cap Value ETF
VBR
$37.1B
$636K 0.01%
3,262
+914
+39% +$169K
ELV icon
342
Elevance Health
ELV
$81.9B
$630K 0.01%
1,619
+475
+42% +$191K
LH icon
343
Labcorp
LH
$24.3B
$629K 0.01%
2,398
+125
+5% +$30.4K
BAM icon
344
Brookfield Asset Management
BAM
$74B
$628K 0.01%
+11,352
New +$609K
L icon
345
Loews
L
$24.3B
$624K 0.01%
6,804
HES
346
DELISTED
Hess
HES
$623K 0.01%
4,497
+8
+0.2% +$1.08K
BN icon
347
Brookfield
BN
$102B
$619K 0.01%
15,009
IYK icon
348
iShares US Consumer Staples ETF
IYK
$1.39B
$617K 0.01%
8,750
-390
-4% -$27.5K
DGRO icon
349
iShares Core Dividend Growth ETF
DGRO
$42.6B
$608K 0.01%
9,516
+637
+7% +$38.8K
SNA icon
350
Snap-on
SNA
$20.9B
$606K 0.01%
1,948

Similar funds

Glenview Trust's Q2 2025 Portfolio in Review

As of Q2 2025, Glenview Trust held 515 positions worth $5.78B, up 12% from $5.15B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Glenview Trust's Q2 2025 filing shows 41 new, 255 increased, 153 reduced and 11 closed positions. Its largest new stake was Energy Transfer Partners: 77,665 shares worth $1.41M. The largest sale was UnitedHealth, an estimated $13.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Glenview Trust's largest Q2 2025 buy was Energy Transfer Partners: 77,665 shares worth $1.41M.
  • Glenview Trust added most to NXP Semiconductors in Q2 2025, an estimated $13.3M increase.
  • Glenview Trust's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $13.9M.
  • Glenview Trust fully exited Discover Financial Services in Q2 2025, selling an estimated $2.71M.
  • Glenview Trust's ten largest holdings make up 35% of its $5.78B portfolio in Q2 2025.
  • Glenview Trust opened 41 new positions and closed 11 in Q2 2025.
  • Glenview Trust's portfolio value rose 12% quarter-over-quarter to $5.78B.

Based on Glenview Trust's 13F filing for Q2 2025, filed 14 Aug 2025.